Compare SPB & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPB | BHC |
|---|---|---|
| Founded | 1906 | N/A |
| Country | United States | Canada |
| Employees | 3000 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 1994 | 1996 |
| Metric | SPB | BHC |
|---|---|---|
| Price | $82.71 | $5.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $82.40 | $8.00 |
| AVG Volume (30 Days) | 228.0K | ★ 1.6M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 1.21 | N/A |
| Revenue | $3,802,100,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $2.03 | $4.61 |
| Revenue Next Year | $1.85 | N/A |
| P/E Ratio | $65.93 | ★ N/A |
| Revenue Growth | ★ 20.86 | N/A |
| 52 Week Low | $49.99 | $4.41 |
| 52 Week High | $85.49 | $8.69 |
| Indicator | SPB | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 56.23 | 52.59 |
| Support Level | $73.37 | $5.52 |
| Resistance Level | $85.49 | $5.97 |
| Average True Range (ATR) | 2.18 | 0.23 |
| MACD | -0.38 | -0.01 |
| Stochastic Oscillator | 58.17 | 30.22 |
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.